Innovative Mobile Platforms for Clinical Research and Evidence Generation

Advances in mobile technology have opened new pathways for clinical research that go beyond traditional site-centric models. Mobile apps now play a growing role in study visibility, participant engagement, and data collection, both within regulated clinical trials and in healthy-population research.

Rather than replacing clinical trial systems, these platforms operate at a different layer:
they connect people to research, standardise how participation occurs, and enable more continuous, real-world data capture. Over time, this may support more structured datasets, easier study access, and more reliable evidence for analysis and decision-making.

Below are two groups of mobile platforms illustrating this shift.

Mobile Platforms Supporting Clinical Trial Participation

(Patient-facing, trial-specific apps)

Science 37 — Studies App

Focus: Decentralized and hybrid clinical trials

Science 37’s Studies App allows participants to discover, consent to, and take part in clinical trials remotely. The platform reduces dependence on physical sites and lowers participation barriers, particularly for patients who would otherwise not have access to research centers.

• Website: https://www.science37.com

• Google Play: https://play.google.com/store/apps/details?id=com.science37.mobile

Medable — Patient App

Focus: Mobile participation in decentralized and hybrid trials. Medable provides patient-facing mobile applications that support participation in already-enrolled clinical trials, standardising how participants interact with protocol activities across studies.

• Website: https://www.medable.com

• Google Play: https://play.google.com/store/apps/details?id=com.medable.axon.flask

Bowel Research UK — Trials App

Focus: Clinical trial visibility and research access
The Bowel Research UK Trials App is a patient-facing mobile application designed to improve awareness and access to clinical research in bowel and gastrointestinal health. The app enables individuals to discover ongoing studies, explore eligibility at a high level, and learn how to participate in research.

• Website: https://bowelresearchuk.org/trialsapp/

• Google Play: https://play.google.com/store/apps/details?id=com.shoothill.bowelresearchuk

Mobile Platforms for Healthy-Population and Lifestyle Research

(Real-world data, habits, and prevention-focused evidence)

Evidation

Focus: Lifestyle, behavior, and real-world evidence
Evidation engages large populations of mostly healthy participants to collect longitudinal data on activity, sleep, nutrition, and daily habits. It is widely used in prevention, behavioral science, and population-level research.

• Website: https://evidation.com

• Google Play: https://play.google.com/store/apps/details?id=com.achievemint.android

MyFitnessPal

Focus: Nutrition and dietary habits
MyFitnessPal enables structured tracking of food intake and eating patterns. Its large, standardised food database makes it a frequent data source in nutrition and lifestyle studies involving healthy populations.

• Website: https://www.myfitnesspal.com

• Google Play: https://play.google.com/store/apps/details?id=com.myfitnesspal.android

Fitbit

Focus: Physical activity, sleep, and behavioral baselines
Fitbit’s mobile platform captures continuous, passive data through wearables. Fitbit data is commonly used in activity, sleep, and cardiovascular research, often providing baseline context for interventional studies.

• Website: https://www.fitbit.com

• Google Play: https://play.google.com/store/apps/details?id=com.fitbit.FitbitMobile

Why these platforms matter

Across both clinical-trial and healthy-population contexts, mobile research platforms:

• improve visibility and access to research,

• reduce friction in enrollment and participation,

• standardise how data is captured through repeated digital interfaces, and

• generate longitudinal datasets grounded in real-world behavior.

While they do not replace clinical trial systems or protocol governance, they create foundational conditions for more representative research and more usable evidence — including data suitable for secondary analysis and real-world evidence generation.

Disclaimer: This post is provided for informational and educational purposes only.The platforms and mobile applications mentioned are referenced based on publicly available information and are discussed at a conceptual level to illustrate emerging patterns in research access, participation, and data collection.This content does not constitute medical, regulatory, legal, or professional advice, nor does it imply endorsement, validation, or suitability of any platform for specific research or clinical use.

Readers are encouraged to conduct their own research, review official documentation, and assess applicability within their own regulatory, ethical, and institutional contexts.